The current study assesses the tolerability and efficacy of monotherapy with pan-RAF-kinase (Tovorafenib) inhibition for the treatment of children and young adults with craniopharyngioma.
- Investigators
- Elias Sayour, Jennifer F King
- Ages
- 1 Year - 39 Years
- Sexes
- All